New CMS Alzheimer's drug coverage plan raises questions around worth
A Medicare plan for covering new Alzheimer's drugs treatments is reviving thorny questions about whether pricey treatments with modest success slowing the disease's progression are worth the cost and safety concerns.Driving the news: The Centers for Medicare and Medicaid Services on Thursday outlined conditions under which it would expand coverage for a specific class of…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Flood insurance rates spur lawsuit
Health insurance renewal scam targeting some New Yorkers
Advisor News
- Charitable giving tools available for taxpayers; due to expire
- Study: How should lawmakers fix the Social Security gap?
- Could Trump seek revenue via a sharp cut in 401(k) contribution limits?
- The ‘guardrails approach’ to retirement income
- Is there a mismatch between advisor marketing and consumer preferences?
More Advisor NewsAnnuity News
Health/Employee Benefits News
- What They're Not Telling You About Farm Bureau Health Plans
- Many are confused over their health plan design
- Medicaid caps could cost states $1.1 trillion
- ‘It is, frankly, dangerous’: Addiction treatment centers claim insurance denials have increased
- Rehab now more accessible to Nevada Medicaid recipients
More Health/Employee Benefits NewsLife Insurance News
- Unum Group Announces $3.4 Billion Long-Term Care Reinsurance Transaction with Fortitude Re
- Insurance Companies
- Zim's Insurance Market Value Seen At U.S.$2,51bn
- Presentation FY 2024
- Somerset Re Accelerates Growth with Strong Deal Momentum into 2025
More Life Insurance News